These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26863741)

  • 41. Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products.
    Pérez-Moreno G; Cantizani J; Sánchez-Carrasco P; Ruiz-Pérez LM; Martín J; El Aouad N; Pérez-Victoria I; Tormo JR; González-Menendez V; González I; de Pedro N; Reyes F; Genilloud O; Vicente F; González-Pacanowska D
    PLoS One; 2016; 11(1):e0145812. PubMed ID: 26735308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of novel secondary metabolites.
    Franco CM; Coutinho LE
    Crit Rev Biotechnol; 1991; 11(3):193-276. PubMed ID: 1760849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dereplication of microbial extracts and related analytical technologies.
    Ito T; Masubuchi M
    J Antibiot (Tokyo); 2014 May; 67(5):353-60. PubMed ID: 24569671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens.
    Fallarero A; Hanski L; Vuorela P
    Planta Med; 2014 Sep; 80(14):1182-99. PubMed ID: 25221978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening concepts, characterization and structural analysis of microbial-derived bioactive lipopeptides: a review.
    Biniarz P; Łukaszewicz M; Janek T
    Crit Rev Biotechnol; 2017 May; 37(3):393-410. PubMed ID: 27098391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic discovery: combining isolation chip (iChip) technology and co-culture technique.
    Lodhi AF; Zhang Y; Adil M; Deng Y
    Appl Microbiol Biotechnol; 2018 Sep; 102(17):7333-7341. PubMed ID: 29974183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering.
    Sekurova ON; Schneider O; Zotchev SB
    Microb Biotechnol; 2019 Sep; 12(5):828-844. PubMed ID: 30834674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small-molecule elicitation of microbial secondary metabolites.
    Pettit RK
    Microb Biotechnol; 2011 Jul; 4(4):471-8. PubMed ID: 21375710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-content screening of natural products reveals novel nuclear export inhibitors.
    Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
    J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Various methodological approaches in controlled screening of antibiotic producers among the group of Coryneform bacteria].
    Obgol'tseva IO; Kuznetsova OS; Iakovleva EP
    Antibiot Khimioter; 1991 Aug; 36(8):6-10. PubMed ID: 1755714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics in microbial coculture.
    Ueda K; Beppu T
    J Antibiot (Tokyo); 2017 Apr; 70(4):361-365. PubMed ID: 27756913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotics Targeting the 30S Ribosomal Subunit: A Lesson from Nature to Find and Develop New Drugs.
    Giuliodori AM; Spurio R; Milón P; Fabbretti A
    Curr Top Med Chem; 2018; 18(24):2080-2096. PubMed ID: 30360712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuing fascination of exploration in natural substances from microorganisms.
    Takahashi Y
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):6-12. PubMed ID: 27885930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodiversity, chemical diversity and drug discovery.
    Singh SB; Pelaez F
    Prog Drug Res; 2008; 65():141, 143-74. PubMed ID: 18084915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bio-mining the microbial treasures of the ocean: new natural products.
    Imhoff JF; Labes A; Wiese J
    Biotechnol Adv; 2011; 29(5):468-82. PubMed ID: 21419836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.